Contract Development and Manufacturing Organization Market Demand, Size and Competitive Analysis | TechSci Research

Global Contract Development and Manufacturing Organization Market was valued at USD 240.19 Billion in 2023 and is expected to reach USD 346.69 Billion by 2029 with a CAGR of 6.48% during the forecast period. <table><tr><td>Pages</td><td>183</td></tr> <tr><td>Market Size</td><td>2023: USD 240.19 Billion</td></tr> <tr><td>Forecast Market Size</td><td>2029: USD 346.69 Billion</td></tr> <tr><td>CAGR</td><td>2024-2029: 6.48%</td></tr> <tr><td>Fastest Growing Segment</td><td>Finished Dosage Formulation (FDF) Development and Manufacturing</td></tr> <tr><td>Largest Market</td><td>North America</td></tr> <tr><td>Key Players</td><td>1.Catalent Inc.2.Recipharm AB3.Jubilant Pharmova Limited4.Thermo Fisher Scientific Inc.5.Boehringer Ingelheim International GmbH6.Pfizer Inc (Pfizer CentreOne)7.Baxter International Inc. 8.Aenova Holding GmbH9.Lonza Group10. tesa Labtec GmbH</td></tr> </table>

全球合同研发与制造组织市场规模于2023年达到了2401.9亿美元，预计在预测期内将以6.48%的复合年增长率增长，并于2029年增至3466.9亿美元。详见表格：
<table><tr><td>页数</td><td>183</td></tr><tr><td>市场规模</td><td>2023年：2401.9亿美元</td></tr><tr><td>预测市场规模</td><td>2029年：3466.9亿美元</td></tr><tr><td>复合年增长率</td><td>2024-2029年：6.48%</td></tr><tr><td>增长最快的细分市场</td><td>成药制剂（FDF）研发与制造</td></tr><tr><td>最大市场</td><td>北美</td></tr><tr><td>主要参与者</td><td>1.Catalent Inc.2.Recipharm AB3.Jubilant Pharmova Limited4.Thermo Fisher Scientific Inc.5.Boehringer Ingelheim International GmbH6.Pfizer Inc (Pfizer CentreOne)7.Baxter International Inc. 8.Aenova Holding GmbH9.Lonza Group10. tesa Labtec GmbH</td></tr></table>